Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714.

doi:10.1182/blood.2019002852

In the last sentence of the first paragraph under “SS” on page 1704, “CD4⁺/CD7⁻ cells ≥30%, or CD4⁺/CD26⁻ cells ≥40%” should read “CD4⁺/CD7⁻ cells ≥40%, or CD4⁺/CD26⁻ cells ≥30%.” The errors have been corrected in the online version of the article.

View Original Article

2019

Sign in via your Institution

Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714.

Cited By

Email alerts

ASH Publications

American Society of Hematology

Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714. Free

This feature is available to Subscribers Only

My Account

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Willemze R, Cerroni L, Kempf W, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-1714.